Bamco Inc. NY Decreases Stock Holdings in Danaher Corporation $DHR

Bamco Inc. NY lowered its stake in Danaher Corporation (NYSE:DHR) by 36.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,329 shares of the conglomerate’s stock after selling 26,807 shares during the quarter. Bamco Inc. NY’s holdings in Danaher were worth $9,383,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in DHR. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher in the second quarter worth $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the third quarter valued at $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the third quarter valued at $28,000. Finally, Tripletail Wealth Management LLC bought a new position in Danaher in the third quarter valued at about $31,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Wells Fargo & Company raised their target price on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Jefferies Financial Group increased their price objective on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Robert W. Baird set a $251.00 price objective on shares of Danaher in a report on Thursday, January 29th. Leerink Partners boosted their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $253.55.

Danaher Trading Up 0.6%

Danaher stock opened at $187.34 on Monday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The firm has a market capitalization of $132.47 billion, a price-to-earnings ratio of 37.17, a P/E/G ratio of 2.54 and a beta of 0.93. The firm has a 50 day moving average of $218.79 and a 200 day moving average of $215.48. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.14 earnings per share. As a group, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a yield of 0.9%. This is an increase from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is currently 25.40%.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.